Hemorrhagic Fever, Ebola

"Hemorrhagic Fever, Ebola" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLAVIRUS, first occurring in the Sudan and adjacent northwestern (what was then) Zaire.

Descriptor ID	D019142
MeSH Number(s)	C02.782.417.415 C02.782.580.250.400
Concept/Terms	Hemorrhagic Fever, Ebola Hemorrhagic Fever, Ebola Ebola Infection Infection, Ebola Ebola Virus Infection Infection, Ebola Virus Virus Infection, Ebola Ebola Hemorrhagic Fever Ebola Virus Disease

Below are MeSH descriptors whose meaning is more general than "Hemorrhagic Fever, Ebola".

Diseases [C]
Virus Diseases [C02]
RNA Virus Infections [C02.782]
Hemorrhagic Fevers, Viral [C02.782.417]
Hemorrhagic Fever, Ebola [C02.782.417.415]
Mononegavirales Infections [C02.782.580]
Filoviridae Infections [C02.782.580.250]
Hemorrhagic Fever, Ebola [C02.782.580.250.400]

Below are MeSH descriptors whose meaning is related to "Hemorrhagic Fever, Ebola".

Below are MeSH descriptors whose meaning is more specific than "Hemorrhagic Fever, Ebola".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hemorrhagic Fever, Ebola" by people in this website by year, and whether "Hemorrhagic Fever, Ebola" was a major or minor topic of these publications.

Bar chart showing 13 publications over 6 distinct years, with a maximum of 6 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Total
2014	2	2
2015	1	1
2016	6	6
2017	2	2
2020	1	1
2021	1	1

Below are the most recent publications written about "Hemorrhagic Fever, Ebola" by people in Profiles.

Dyal J, Kofman A, Kollie JZ, Fankhauser J, Orone R, Soka MJ, Glaybo U, Kiawu A, Freeman E, Giah G, Tony HD, Faikai M, Jawara M, Kamara K, Kamara S, Flowers B, Kromah ML, Desamu-Thorpe R, Graziano J, Brown S, Morales-Betoulle ME, Cannon DL, Su K, Linderman SL, Plucinski M, Rogier E, Bradbury RS, Secor WE, Bowden KE, Phillips C, Carrington MN, Park YH, Martin MP, Aguinaga MDP, Mushi R, Haberling DL, Ervin ED, Klena JD, Massaquoi M, Nyenswah T, Nichol ST, Chiriboga DE, Williams DE, Hinrichs SH, Ahmed R, Vonhm BT, Rollin PE, Purpura LJ, Choi MJ. Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia. Clin Infect Dis. 2023 02 08; 76(3):e849-e856.

View in: PubMed
Kofman A, Linderman S, Su K, Purpura LJ, Ervin E, Brown S, Morales-Betoulle M, Graziano J, Cannon DL, Klena JD, Desamu-Thorpe R, Fankhauser J, Orone R, Moses S, Glaybo U, Massaquoi M, Nyenswah T, Nichol ST, Kollie J, Kiawu A, Freeman E, Giah G, Tony H, Faikai M, Jawara M, Kamara K, Kamara S, Flowers B, Mohammed K, Chiriboga D, Williams DE, Hinrichs SH, Ahmed R, Vonhm B, Rollin PE, Choi MJ. Characteristics of Ebola Virus Disease Survivor Blood and Semen in Liberia: Serology and Reverse Transcription Polymerase Chain Reaction (RT-PCR). Clin Infect Dis. 2021 12 06; 73(11):e3641-e3646.

View in: PubMed
Murray LP, Govindan R, Mora AC, Munro JB, Mace CR. Antibody affinity as a driver of signal generation in a paper-based immunoassay for Ebola virus surveillance. Anal Bioanal Chem. 2021 Jun; 413(14):3695-3706.

View in: PubMed
Kanagasabai U, Enriquez K, Gelting R, Malpiedi P, Zayzay C, Kendor J, Fahnbulleh S, Cooper C, Gibson W, Brown R, Nador N, Williams DE, Chiriboga D, Niescierenko M. The Impact of Water Sanitation and Hygiene (WASH) Improvements on Hand Hygiene at Two Liberian Hospitals during the Recovery Phase of an Ebola Epidemic. Int J Environ Res Public Health. 2021 03 25; 18(7).

View in: PubMed
Barnes KG, Lachenauer AE, Nitido A, Siddiqui S, Gross R, Beitzel B, Siddle KJ, Freije CA, Dighero-Kemp B, Mehta SB, Carter A, Uwanibe J, Ajogbasile F, Olumade T, Odia I, Sandi JD, Momoh M, Metsky HC, Boehm CK, Lin AE, Kemball M, Park DJ, Branco L, Boisen M, Sullivan B, Amare MF, Tiamiyu AB, Parker ZF, Iroezindu M, Grant DS, Modjarrad K, Myhrvold C, Garry RF, Palacios G, Hensley LE, Schaffner SF, Happi CT, Colubri A, Sabeti PC. Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. Nat Commun. 2020 08 17; 11(1):4131.

View in: PubMed
Ollmann Saphire E. A Vaccine against Ebola Virus. Cell. 2020 04 02; 181(1):6.

View in: PubMed
Saphire EO. A glimpse into immune responses evolving against Ebola virus. Nat Med. 2019 10; 25(10):1470-1471.

View in: PubMed
King LB, Milligan JC, West BR, Schendel SL, Ollmann Saphire E. Achieving cross-reactivity with pan-ebolavirus antibodies. Curr Opin Virol. 2019 02; 34:140-148.

View in: PubMed
Bramble MS, Hoff N, Gilchuk P, Mukadi P, Lu K, Doshi RH, Steffen I, Nicholson BP, Lipson A, Vashist N, Sinai C, Spencer D, Olinger G, Wemakoy EO, Illunga BK, Pettitt J, Logue J, Marchand J, Varughese J, Bennett RS, Jahrling P, Cavet G, Serafini T, Ollmann Saphire E, Vilain E, Muyembe-Tamfum JJ, Hensely LE, Simmons G, Crowe JE, Rimoin AW. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors. J Infect Dis. 2018 11 05; 218(12):1929-1936.

View in: PubMed
McQuilkin PA, Niescierenko M, Beddoe AM, Goentzel J, Graham EA, Henwood PC, Rehwaldt L, Teklu S, Tupesis J, Marshall R. Academic Medical Support to the Ebola Virus Disease Outbreak in Liberia. Acad Med. 2017 12; 92(12):1674-1679.

View in: PubMed

People

Explore

Similar Concepts

Top Journals